Law firm Parker Waichman has filed multiple lawsuits alleging that patients developed NAION, a rare and irreversible optic nerve condition causing permanent vision loss, after taking Novo Nordisk's semaglutide drugs Wegovy and Ozempic. A Massachusetts plaintiff's suit was filed on June 5, 2026. The claims cite studies, including one in JAMA Ophthalmology and Mass Eye and Ear research, suggesting increased NAION risk among semaglutide users. The litigation alleges the manufacturer failed to adequately warn about the risk.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.